Cellectis SA ADR buy Quitte
Start price
29.02.16
/
50%
€21.07
Target price
18.03.16
€24.35
Performance (%)
15.63%
End price
18.03.16
€24.36
Summary
This prediction ended on 18.03.16 with a price of €24.36. The BUY prediction by Quitte finished with a performance of 15.63%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -5.147% | -5.147% | 126.316% | 47.429% |
| iShares Core DAX® | 2,90 % | 3,65 % | 5,76 % | 49,36 % |
| iShares Nasdaq 100 | 4,60 % | 3,06 % | 36,95 % | 89,09 % |
| iShares Nikkei 225® | 10,42 % | 12,61 % | 64,98 % | 72,73 % |
| iShares S&P 500 | 2,57 % | 1,36 % | 25,17 % | 65,39 % |
Comments by Quitte for this prediction
In the thread Cellectis SA ADR diskutieren
gutes Rating und eventuell ein Boden
Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.